Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
about
Drug delivery systems, CNS protection, and the blood brain barrierManaging inflammation after spinal cord injury through manipulation of macrophage functionNew perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.Serotonergic transmission after spinal cord injury.Development of in vivo drug-induced neurotoxicity models.Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.
P2860
Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
@en
type
label
Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
@en
prefLabel
Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
@en
P1476
Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair.
@en
P2093
Aruna Sharma
Hari Shanker Sharma
P356
10.1016/B978-0-12-386986-9.00002-8
P577
2012-01-01T00:00:00Z